Usefulness and Future Prospects of Confocal Laser Endomicroscopy for Gastric Premalignant and Malignant Lesions.
- Author:
Sang Kil LEE
1
Author Information
- Publication Type:Review
- Keywords: Confocal laser endomicroscopy; Stomach neoplasms; Gastric intestinal metaplasia
- MeSH: Barrett Esophagus; Biopsy; Diagnosis; Endoscopy; Esophageal Diseases; Helicobacter pylori; Mass Screening; Metaplasia; Risk Factors; Stomach; Stomach Neoplasms
- From:Clinical Endoscopy 2015;48(6):511-515
- CountryRepublic of Korea
- Language:English
- Abstract: Confocal laser endomicroscopy (CLE) is a new technology enabling endoscopists to visualize tissue at the cellular level. CLE has the fundamental potential to provide a histologic diagnosis, and may theoretically replace or reduce the need for performing biopsy for histology. The clinical benefits of CLE are more obvious in esophageal disease, including Barrett's esophagus. Currently, this technology has been adapted to the diagnosis and surveillance of Barrett's esophagus and related neoplasia. Standard white light endoscopy is the primary tool for gastric cancer screening. Currently, the only method available to precisely diagnose these lesions is upper endoscopy with an appropriate biopsy. A recent study showed that CLE could characterize dysplasia or cancer and identify the risk factors for gastric cancer, such as intestinal metaplasia and the presence of Helicobacter pylori in vivo, although fewer studies on CLE were performed on the stomach than on Barrett's esophagus and other esophageal diseases. However, the application of CLE to routine clinical endoscopy continues to be refined. This review focused on the usefulness and future prospects of CLE for gastric premalignant and malignant lesions.
